Financials

  • Market Capitalization 12.66 B
  • Employee 4 700
  • Founded 2004
  • CEO Adam Elsesser
  • Website www.penumbrainc.com
  • Headquarter Delaware, United States
  • FIGI BBG001BP92V1
  • Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
68.79
Price to sales ratio
8.7

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
616
ZBH
Zimmer Biomet Holdings, Inc. Common Stock
99.48 USD-1.87%+0.76%+4.38%-3.88%18.97 B USD
794
SNN
Smith & Nephew SNATS Inc
29.14 USD-0.58%+1.18%-9.62%-20.49%12.79 B USD
867
GMED
Globus Medical, Inc. Class A Common Stock
82.55 USD-0.69%-3.44%+3.56%+34.67%11.08 B USD
883
GKOS
Glaukos Corporation Common Stock
181.91 USD+0.63%-1.51%+24.78%+88.51%10.73 B USD

Frequently asked questions about Penumbra, Inc.

What is the Penumbra, Inc. stock price today?

The current price of Penumbra, Inc. (PEN) is 321.33. Over the past 24 hours, the stock has changed by -0.57%. Follow the PEN chart for real-time price dynamics.

What is the stock ticker of Penumbra, Inc.?

Penumbra, Inc. trades under the ticker PEN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Penumbra, Inc. stock going up?

PEN has changed by -1.01% over the last week, +1.21% over the last month, and +23.59% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Penumbra, Inc.?

Penumbra, Inc. currently has a market capitalization of 12.66 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Penumbra, Inc. earnings last quarter?

Last quarter, Penumbra, Inc. reported earnings of 0.88 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Penumbra, Inc. revenue for the last quarter?

Penumbra, Inc. reported quarterly revenue of 390.05 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Penumbra, Inc. net income for the last quarter?

Penumbra, Inc. reported net income of 34.81 M for the last quarter. The previous quarter showed 32.58 M, which means net income changed by +6.83%.

How many employees does Penumbra, Inc. have?

As of the latest available data, Penumbra, Inc. has 4 700 employees. Workforce size can provide additional context about the company's scale and operations.

What is Penumbra, Inc. EBITDA?

Penumbra, Inc. EBITDA is 46.65 M, and its EBITDA margin is 11.96%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Penumbra, Inc. stock?

You can buy Penumbra, Inc. (PEN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Penumbra, Inc. stock?

Investing in Penumbra, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PEN chart and related analysis on metatrader.com as part of your research.

Penumbra, Inc. Common Stock

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end.

News